Anxiolytic-like activity of SB-205384 in the elevated plus maze test in mice

Psicothema

Volumn 18, Issue 1, 2006, Pages 100-104

  Navarro, José Francisco ^a   Burón, Estrella ^a   Martin López, Mercedes ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 5,6,7,8 TETRAHYDRO 7 HYDROXY 2 METHYLBENZO[B]THIENO[2,3 B]PYRIDINE 3 CARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA3 SUBUNIT, GABA A RECEPTOR; ALPHA3 SUBUNIT, GABA-A RECEPTOR; AMINOPYRIDINE DERIVATIVE; ANXIOLYTIC AGENT; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; MENTAL STRESS; MOUSE; PHYSIOLOGY; RANDOMIZATION;

AMINOPYRIDINES; ANIMALS; ANTI-ANXIETY AGENTS; DRUG EVALUATION, PRECLINICAL; EXPLORATORY BEHAVIOR; GABA AGONISTS; MALE; MAZE LEARNING; MICE; RANDOM ALLOCATION; RECEPTORS, GABA-A; STRESS, PSYCHOLOGICAL; THIOPHENES;

EID: 33750584401     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Atack, J.R., Hutson, P.H., Collinson, N., Marshall, G., Bentley, G., Moyes, Ch., Cook, S.M., Collins, I., Wafford, K., McKernan, R.M. and Dawson, G.R. (2005). Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABA-A receptors. British Journal of Pharmacology, 144, 357-366.
2. Belzung, C. and Griebel, G. (2001). Measuring normal and pathological anxiety-like behavior in mice: a review. Behavioral Brain Research, 125, 141-149.
3. Collins, I., Moyes, C., Davey, W.B., Rowley, M., Bromidge, F.A., Quirk, K., Atack, J.R., McKernan, R.M., Thompson, S.A., Wafford, K., Dawson, G.R., Pike, A., Sohal, B., Tsou, N.N., Ball, R.G. and Castro, J.L. (2002). 3-Heteroaryl-2-pyridones: benzodiazepine site ligandss with functional selectivity for α2/α3-subtypes of human GABA-A receptorion channels. Journal of Medical Chemistry, 45, 1.887-1.900.
4. Crestani, F., Low, K., Keist, R., Mandelli, M.J., Möhler, H. and Rudolph, U. (2001). Molecular targets for the myorelaxant action of diazepam. Molecular Pharmacology, 59, 442-445.
5. Fritschy, J.M. and Brunig, I. (2003). Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacology and Therapeutics, 5.539, 1-25.
6. Gao, B., Fritschy, J.M., Benke, D. and Möhler, H. (1993). Neuron-specific expression of GABA-A-receptor subtypes: differential associations of the α1- and α3-subunits with serotonergic and GABAergic neurons. Neuroscience, 54, 881-892.
7. Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Depoortere, H., Francon, D., Avenet, P., Shoemaker, H., Evanno, Y., Sevrin, M., George, P. and Scatton, B. (2003). SL651498, a GABA(A) receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Reviews, 9, 3-20.
8. Kneussel, M. (2002). Dynamic regulation of GABA-A receptors at synaptic sites. Brain Research Reviews, 39, 74-83.
9. Lister, R.G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180-185.
10. Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J.A., Fritschy, J.M., Rülicke, T., Bluethmann, H., Möhler, H. and Rudolph, U. (2000). Molecular and neuronal substrate for the selective attenuation of anxiety. Science, 290, 131-134.
11. Manzaneque, J.M., Brain, P.F. and Navarro, J.F. (2002). Effects of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test. Progress in NeuroPsychopharmacnlogy & Biological Psychiatry, 26, 349-355.
12. Martín-Löpez, M. and Navarro, J.F. (2002). Antiaggressive effects of zolpidem and zopiclone in agonistic encounters between male mice. Aggressive Behavior, 28, 416-425.
13. McKernan, R.M., Rosahl, T.W., Reynolds, D.S., Sur, C., Wafford, K.A., Atack, J.R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garret, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K.W., Carling, R.W., Street, L.J., Castro, J.L., Ragan, C.I., Dawson, G.R. and Whiting, P.J. (2000). Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA-A receptor al subtype. Nature Neuroscience, 3, 587-592.
14. Meadows, H.J., Harries, M.H., Thompson, M. and Benham, C.D. (1997). Effect of SB-205384 on the decay of GABA-activated chloride currents in granule cells cultured from rat cerebellum. British Journal of Pharmacology, 121, 1.334-1.338.
15. Meadows, H.J., Kumar, C.S., Pritchett, D.B., Blackburn,T.P. and Benham, C.D. (1998). SB-205384: a GABA-A receptor modulator with novel mechanism of action that shows subunit selectivity. British Journal of Pharmacology, 123, 1.253-1.259.
16. Möhler, H., Crestani, F. and Rudolph, U. (2001). GABAA-receptor subtypes: a new pharmacology. Current Opinion in Neurobiology, 1, 22-25.
17. Navarro, J.F. and Maldonado, E. (2002). Acute and subchronic effects of MDMA («ecstasy») on anxiety in male mice tested in the elevated plus-maze. Progress in NeuroPsychopharmacology & Biological Psychiatry, 26, 1.151-1.154.
18. Navarro, J.F., Burön, E. and Marti'n-Löpez, M. (2002). Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the α5 subunit, in the elevated plusmaze test. Progress in NeuroPsychopharmacology & Biological Psychiatry, 26, 1.389-1.392.
19. Navarro, J.F., Luna, G., García, F. and Pedraza, C. (2003). Effects of L-741, 741, a selective D4 dopamine receptor antagonist, on anxiety tested in the elevated plus-maze in mice. Methods and Findings in Experimental and Clinical Pharmacology, 25, 45-47.
20. Navarro, J.F., Luna, G. and García, F. (2005). Acute and subchronic effects of agmatine on anxiety tested in the elevated plus maze in male mice. Psicothema, 17, 492-495.
21. Ohl, F. (2003). Testing for anxiety. Clinical and Neuroscience Research, 3, 233-238.
22. Patel, J.B. and Malick, J.B. (1982). Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolityc agent. European Journal of Pharmacology, 78, 323-333.
23. Rodgers, R.J. and Johnson, N.J.T. (1995). Factor analysis of spatiotemporal and ethological measures in the murine elevated-plus maze. Pharmacology Biochemistry and Behavior, 52, 805-813.
24. Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J.A., Fritschy, J.M., Martin, J.R., Bluethmann, H. and Möhler, H. (1999). Benzodiazepine actions mediated by specific GABA-A receptor subtypes. Nature, 401, 796-800.
25. Rudolph, U. and Möhler, H. (2004). Analysis of GABA-A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology and Toxicology, 44, 475-498.
26. Sanna, E., Busonero, F., Talani, G., Carta, M., Massa, F., Pels, M., Maciocco, E. und Biggio, G. (2002). Comparison of the effects of zale pion, zolpidcm and triazolam at various GABA-A receptor subtypes. European Journal of Pharmacology, 451, 103-110.
27. Steiger, J.L. and Russek, S.J. (2004). GABA-A receptors: building the bridge between subunit mRNAs, their promoters and cognate transcription factors. Pharmacology and Therapeutics, 101, 259-281.
28. Thompson, S.A., Wingrove, P.E., Connelly, L., Whiting, P.J. and Wafford, K.A. (2002). Tracazolate reveals a novel type of allosteric interactions with recombinant GABA-A receptors. Molecular Pharmacology, 61, 861-869.
29. Young, R., Urbancic, A., Emrey, T.A., Hall, P.C. and Metcalf, G. (1987). Behavioral effects of several new anxiolytic and putative anxiolytics. European Journal of Pharmacology, 143, 361-371.